Mesothelioma Treating Physicians
 |
Dr. Robert Cameron - Los Angeles, California Dr. Cameron is a surgical oncologist and mesothelioma specialist, Director of the Mesothelioma Program at UCLA Medical School. Phone: (310) 794-7333 "Rational Versus Radical Therapy For Mesothelioma: A New Approach," Dr. Robert Cameron, UCLA Medical School, presented at MARF Symposium in Las Vegas, October 16, 2004. Copyright of Dr. Robert Cameron. Do not copy without permission (11/18/04) UCLA Proposes Comprehensive Mesothelioma
Translational Research Program (5/10/04) |
 |
Dr. Larry Kaiser - Philadelphia, Pennsylvania Dr. Kaiser is a cardiothoracic surgeon at the University of Pennsylvania Center for Lung Cancer & Related Disorders. University of Pennsylvania email: Kaiser@mail.med.upenn.edu.
|
 |
Dr. Brian Loggie - Omaha, Nebraska Dr. Loggie is Professor of Surgery and Director for: Phone: 402-280-3273
|
 |
Dr. Harvey Pass - New York, New York Dr. Harvey Pass is Professor and Chief of the Division of Thoracic Surgery and Thoracic Oncology at the New York University School of Medicine and Comprehensive Cancer Center. Dr. Pass has studied pleural mesothelioma since 1988 when he was the Head of Thoracic Oncology and Senior Investigator of the Surgery Branch of the National Cancer Institute in Bethesda. Dr. Pass combines cytoreductive surgery, either EPP or pleurectomy, with innovative or standard adjuvant therapies including novel antiangiogenesis inhibitors postoperatively or chemotherapy combinations. His Thoracic Oncology laboratory is pursuing the study of proteins (proteomics) and gene expression profiles in mesothelioma to develop new early detection strategies, as well as designing alternate innovative treatments which use novel proteins as targets for mesothelioma Curriculum Vitae (resume), Dr. Harvey Pass. March 26, 2003 Dr. Pass is the Chairman of the Science Advisory Board of the Mesothelioma Applied Research Foundation (MARF). Professor and Chief, Division of Thoracic
Surgery and Thoracic Oncology Phone: 212.263.7417 Malignant Pleural Mesothelioma: Surgical
Roles and Novel Therapies, preface by Roger G. Worthington (2/7/02) |
 |
Dr. Lary A. Robinson - Tampa, Florida Dr. Robinson is a thoracic surgical oncologist with expertise in treating mesothelioma patients. Dr. Robinson is on the Science
Advisory Board of the Mesothelioma Applied Research Foundation (MARF). Phone: 813.979.3050
|
 |
Dr. W. Roy Smythe - Temple, Texas Dr. W. Roy Smythe is involved in the surgical diagnosis and treatment of mesothelioma patients. He has designed a pilot protocol at M. D. Anderson for malignant pleural mesothelioma involving aggressive surgical therapy followed by intensity modulated radiation therapy (IMRT). In the laboratory, he was involved in the initial research work evaluating gene therapy for this disease in the mid 1990's at the University of Pennsylvania. He is currently evaluating a number of novel gene therapy and molecular approaches to the treatment of this disease, and hopes to bring one or more of these to the clinic in the next year. Curriculum Vitae (resume), Dr. W.Roy Smythe. October 16, 2001 Dr. Smythe is on the Science Advisory Board of the Mesothelioma Applied Research Foundation (MARF). Dr. W. Roy Smythe Phone: 254.724.2595
|
 |
Dr. David Sugarbaker - Boston, Massachusetts
Dr. Sugarbaker is a surgical oncologist with expertise in treating
mesothelioma patients. Dr. Sugarbaker has pioneered the "tri-modal" therapy
approach. Phone: 617.732.6824 |
 |
Dr. Robert Taub - New York, New York
Dr. Taub is a medical oncologist who directs the Connective Tissue Oncology Program at the Herbert Irving Comprehensive Cancer Center, where there are a number of ongoing multimodality studies of patients with pleural and peritoneal mesothelioma. Dr. Taub is on the Science
Advisory Board of the Mesothelioma Applied Research Foundation (MARF). Phone: 212.305.4076 |
 |
Dr. Eric Vallieres - Seattle, Washington
Dr. Vallières is a surgical oncologist who since 1997 has been the principal investigator of a Phase II multi-modal trial for mesothelioma patients at the University of Washington Medical Center. He now practices at the Swedish Cancer Institute. Dr. Vallières
is on the Science Advisory Board of the Mesothelioma Applied Research
Foundation (MARF). Eric Vallières MD FRCSC Phone: 206.-215.6800 |
 |
Dr. Claire Verschraegen - Albuquerque, New Mexico
Dr. Verschraegen is an oncologist and Director of Experimental Therapeutics at the University of New Mexico. Dr. Verschraegen is on the Science Advisory Board of the Mesothelioma Applied Research Foundation (MARF). Director of Experimental Therapeutics University of New Mexico Phone: 505.272.5837 |
 |
Dr. Nicholas Vogelzang - Las Vegas, Nevada
Dr. Vogelzang is a thoracic surgical oncologist with interests in clinical trials in genitourinary malignancies and mesothelioma. He is a recognized expert in new therapies for patients with metastatic kidney cancer, including genetic therapy, new cytokine therapy, and combination. Dr. Vogelzang is on the Board of Directors
of the Mesothelioma Applied Research Foundation (MARF). Phone: 702.821.0000 ASCO Reports on Intracavitary Hyperthermic Chemo, FDG-PET Scan Prognostication, and Alimta/Cisplatin Quality of Life (6/12/03) Unresectable Mesothelioma: A New Standard of Care
(5/29/02) |
Picture Not Available |
Dr. Paul Sugarbaker - Washington, D.C
Sugarbaker Oncology Associates, P.C. Phone: 202.877.3908 Sugarbaker Oncology Associates, Washington Cancer Institute,
Washington Hospital Center, Washington, D.C. "We specialize
in the surgical treatment of cancers that arise in the gastrointestinal
tract, such
as abdominal (Peritoneal) mesotheliomas." |
Picture Not Available |
Dr. Valerie Rusch - New York, New York
Memorial Sloan-Kettering Cancer Center Phone: 212.639.5873 |
Picture Not Available |
Dr. David Jablons - San Francisco, California
Mt. Zion Medical Center/USCF Phone: 415.885.3882 |